Literature DB >> 15855186

The response to anti-TNF-alpha treatment: gene regulation at the bedside.

N de Vries, P P Tak.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15855186     DOI： 10.1093/rheumatology/keh662

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN： 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  7 in total

Review 1.  Selected cytokine pathways in rheumatoid arthritis.

Authors:  Mélissa Noack; Pierre Miossec
Journal:  Semin Immunopathol       Date:  2017-02-17       Impact factor: 9.623

Review 2.  Pharmacogenetics of etanercept in rheumatoid arthritis.

Authors:  Maria I Danila; Laura B Hughes; S Louis Bridges
Journal:  Pharmacogenomics       Date:  2008-08       Impact factor: 2.533

3.  Protein biochip array technology to monitor rituximab in rheumatoid arthritis.

Authors:  S Fabre; C Guisset; L Tatem; N Dossat; A M Dupuy; J D Cohen; J P Cristol; J P Daures; C Jorgensen
Journal:  Clin Exp Immunol       Date:  2009-03       Impact factor: 4.330

4.  Protein biochip array technology for cytokine profiling predicts etanercept responsiveness in rheumatoid arthritis.

Authors:  S Fabre; A M Dupuy; N Dossat; C Guisset; J D Cohen; J P Cristol; J P Daures; C Jorgensen
Journal:  Clin Exp Immunol       Date:  2008-06-18       Impact factor: 4.330

5.  Contribution for new genetic markers of rheumatoid arthritis activity and severity: sequencing of the tumor necrosis factor-alpha gene promoter.

Authors:  João Eurico Fonseca; João Cavaleiro; José Teles; Elsa Sousa; Valeska L Andreozzi; Marília Antunes; Maria A Amaral-Turkman; Helena Canhão; Ana F Mourão; Joana Lopes; Joana Caetano-Lopes; Pamela Weinmann; Marta Sobral; Patrícia Nero; Maria J Saavedra; Armando Malcata; Margarida Cruz; Rui Melo; Araceli Braña; Luis Miranda; José V Patto; Anabela Barcelos; José Canas da Silva; Luís M Santos; Guilherme Figueiredo; Mário Rodrigues; Herberto Jesus; Alberto Quintal; Teresa Carvalho; José A Pereira da Silva; Jaime Branco; Mário Viana Queiroz
Journal:  Arthritis Res Ther       Date:  2007       Impact factor: 5.156

6.  Lack of association of -863C/A (rs1800630) polymorphism of tumor necrosis factor-a gene with rheumatoid arthritis.

Authors:  Tayyaba Sadaf; Peter John; Attya Bhatti; Javaid M Malik
Journal:  Arch Med Sci       Date:  2018-07-05       Impact factor: 3.318

7.  The clinical response to infliximab in rheumatoid arthritis is in part dependent on pretreatment tumour necrosis factor alpha expression in the synovium.

Authors:  C A Wijbrandts; M G W Dijkgraaf; M C Kraan; M Vinkenoog; T J Smeets; H Dinant; K Vos; W F Lems; G J Wolbink; D Sijpkens; B A C Dijkmans; P P Tak
Journal:  Ann Rheum Dis       Date:  2007-11-29       Impact factor: 19.103
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.